Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Related Articles by Review for PubMed (Select 22057700)

1.

Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.

von Wyl V, Yerly S, Böni J, Shah C, Cellerai C, Klimkait T, Battegay M, Bernasconi E, Cavassini M, Furrer H, Hirschel B, Vernazza PL, Ledergerber B, Günthard HF; Swiss HIV Cohort Study.

Clin Infect Dis. 2012 Jan 1;54(1):131-40. doi: 10.1093/cid/cir728. Epub 2011 Nov 4.

2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
3.

WITHDRAWN: Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.

Omeje I, Okwundu CI.

Cochrane Database Syst Rev. 2012 May 16;5:CD007276. doi: 10.1002/14651858.CD007276.pub3. Review.

PMID:
22592718
4.

WITHDRAWN. Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.

Omeje I, Okwundu CI.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD007276. doi: 10.1002/14651858.CD007276.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD007276.

PMID:
22336829
6.

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C.

Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Review.

PMID:
20731472
7.

Strategies for overcoming resistance in HIV-1 infected patients receiving HAART.

Clotet B.

AIDS Rev. 2004 Jul-Sep;6(3):123-30. Review.

PMID:
15595429
8.

The use of human immunodeficiency virus resistance tests in clinical practice.

Ceccherini-Silberstein F, Cento V, Calvez V, Perno CF.

Clin Microbiol Infect. 2010 Oct;16(10):1511-7. doi: 10.1111/j.1469-0691.2010.03353.x. Review.

9.

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines.

Colombo GL, Di Matteo S, Antinori A, Medaglia M, Murachelli S, Rizzardini G.

Clinicoecon Outcomes Res. 2013 Oct 3;5:489-96. doi: 10.2147/CEOR.S48246. Review.

10.

Genotypic resistance testing in routine clinical care.

Dunn DT, Coughlin K, Cane PA.

Curr Opin HIV AIDS. 2011 Jul;6(4):251-7. doi: 10.1097/COH.0b013e32834732e8. Review.

PMID:
21646877
11.

Recent trends in HIV-1 drug resistance.

Siliciano JD, Siliciano RF.

Curr Opin Virol. 2013 Oct;3(5):487-94. doi: 10.1016/j.coviro.2013.08.007. Epub 2013 Sep 7. Review.

12.

The quad pill, a once-daily combination therapy for HIV infection.

Johnson LB, Saravolatz LD.

Clin Infect Dis. 2014 Jan;58(1):93-8. doi: 10.1093/cid/cit637. Epub 2013 Sep 24. Review.

13.

Multi-classifier based on hard instances- new method for prediction of human immunodeficiency virus drug resistance.

Bonet I, Arencibia J, Pupo M, Rodriguez A, García MM, Grau R.

Curr Top Med Chem. 2013;13(5):685-95. Review.

PMID:
23548029
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk